Dexcom (DXCM) EBIT Margin (2010 - 2026)
Dexcom (DXCM) reported EBIT Margin of 21.42% for Q1 2026, up 851.0% year-over-year from 2.25% in Q1 2025, and down 16.47% quarter-over-quarter from 25.64% in Q4 2025.
Dexcom (DXCM) EBIT Margin (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has 17 years of EBIT Margin data on file, last reported at 21.42% in Q1 2026.
- EBIT Margin for Q1 2026 came in at 21.42%, up 851.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 21.45% (up 620.0% YoY), and the FY2025 annual result was 19.56%, up 468.0% from the prior year.
- EBIT Margin eased to 21.42% in Q1 2026 per DXCM's latest filing, from 25.64% in the prior quarter.
- Over five years, EBIT Margin peaked at 25.64% in Q4 2025 and troughed at 6.37% in Q1 2023.
- A 5-year average of 16.04% and a median of 15.73% in 2024 frame the typical range for EBIT Margin.
- On a YoY basis, EBIT Margin climbed as much as 1530 bps in 2022 and fell as far as 591 bps in 2022.
- A 5-year view of EBIT Margin shows it stood at 15.38% in 2022, then surged by 36 bps to 20.97% in 2023, then dropped by 19 bps to 16.96% in 2024, then surged by 51 bps to 25.64% in 2025, then slipped by 16 bps to 21.42% in 2026.
- Business Quant data shows DXCM's EBIT Margin at 21.42% in Q1 2026, 25.64% in Q4 2025, and 20.05% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 17.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.42% |
| Dec 31, 2025 | 25.64% |
| Sep 30, 2025 | 20.05% |
| Jun 30, 2025 | 18.37% |
| Mar 31, 2025 | 12.91% |
| Dec 31, 2024 | 16.96% |
| Sep 30, 2024 | 15.29% |
| Jun 30, 2024 | 15.73% |
| Mar 31, 2024 | 10.98% |
| Dec 31, 2023 | 20.97% |
| Sep 30, 2023 | 21.08% |
| Jun 30, 2023 | 14.70% |
| Mar 31, 2023 | 6.37% |
| Dec 31, 2022 | 15.38% |
| Sep 30, 2022 | 19.17% |
| Jun 30, 2022 | 11.06% |
| Mar 31, 2022 | 6.57% |
| Dec 31, 2021 | 0.09% |
| Sep 30, 2021 | 18.19% |
| Jun 30, 2021 | 16.97% |